Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
The Laryngoscope
|
December 21, 2007
Molecular classification of thyroid nodules by cytology
Nitin A Pagedar, Daniel H Chen, Jay K Wasman, et al.
Surgery
|
May 18, 2024
What constitutes quality in endocrine surgery? Statement from the American Association of Endocrine Surgeons
Aarti Mathur, Kepal N Patel, Scott M Wilhelm, et al.
International Journal of Cancer
|
December 21, 2010
Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity
Scott M Wilhelm, Jacques Dumas, Lila Adnane, et al.
Surgical Endoscopy
|
November 1, 2021
A comparison of robotic and laparoscopic minimally invasive adrenalectomy for adrenal malignancies
Jonathan J Hue, Peter Ahorukomeye, Katherine Bingmer, et al.
Annals of Surgical Oncology
|
August 11, 2007
Outcomes of pheochromocytoma management in the laparoscopic era
Carmen C Solorzano, John I Lew, Scott M Wilhelm, et al.
Surgery
|
October 12, 2014
Feasibility of surgeon-performed transcutaneous vocal cord ultrasonography in identifying vocal cord mobility: A multi-institutional experience
Denise Carneiro-Pla, Barbra S Miller, Scott M Wilhelm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 15, 2006
BRAF is a therapeutic target in aggressive thyroid carcinoma
Giuliana Salvatore, Valentina De Falco, Paolo Salerno, et al.
International Journal of Cancer
|
December 19, 2013
Regorafenib (BAY 73-4506): antitumor and antimetastatic activities in preclinical models of colorectal cancer
Roberta Schmieder, Jens Hoffmann, Michael Becker, et al.
Molecular Cancer Therapeutics
|
October 31, 2013
BAY 80-6946 is a highly selective intravenous PI3K inhibitor with potent p110α and p110δ activities in tumor cell lines and xenograft models
Ningshu Liu, Bruce R Rowley, Cathy O Bull, et al.
JAMA Surgery
|
August 18, 2016
The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism
Scott M Wilhelm, Tracy S Wang, Daniel T Ruan, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
The Laryngoscope
|
December 21, 2007
Molecular classification of thyroid nodules by cytology
Nitin A Pagedar, Daniel H Chen, Jay K Wasman, et al.
Surgery
|
May 18, 2024
What constitutes quality in endocrine surgery? Statement from the American Association of Endocrine Surgeons
Aarti Mathur, Kepal N Patel, Scott M Wilhelm, et al.
International Journal of Cancer
|
December 21, 2010
Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity
Scott M Wilhelm, Jacques Dumas, Lila Adnane, et al.
Surgical Endoscopy
|
November 1, 2021
A comparison of robotic and laparoscopic minimally invasive adrenalectomy for adrenal malignancies
Jonathan J Hue, Peter Ahorukomeye, Katherine Bingmer, et al.
Annals of Surgical Oncology
|
August 11, 2007
Outcomes of pheochromocytoma management in the laparoscopic era
Carmen C Solorzano, John I Lew, Scott M Wilhelm, et al.
Surgery
|
October 12, 2014
Feasibility of surgeon-performed transcutaneous vocal cord ultrasonography in identifying vocal cord mobility: A multi-institutional experience
Denise Carneiro-Pla, Barbra S Miller, Scott M Wilhelm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 15, 2006
BRAF is a therapeutic target in aggressive thyroid carcinoma
Giuliana Salvatore, Valentina De Falco, Paolo Salerno, et al.
International Journal of Cancer
|
December 19, 2013
Regorafenib (BAY 73-4506): antitumor and antimetastatic activities in preclinical models of colorectal cancer
Roberta Schmieder, Jens Hoffmann, Michael Becker, et al.
Molecular Cancer Therapeutics
|
October 31, 2013
BAY 80-6946 is a highly selective intravenous PI3K inhibitor with potent p110α and p110δ activities in tumor cell lines and xenograft models
Ningshu Liu, Bruce R Rowley, Cathy O Bull, et al.
JAMA Surgery
|
August 18, 2016
The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism
Scott M Wilhelm, Tracy S Wang, Daniel T Ruan, et al.
Page
of 5